Obesity is a global health crisis, increasing the risk of chronic conditions like diabetes, heart disease, and metabolic ...

University Medical Center New Orleans is expanding its bariatric program – the Center for Weight Loss and Bariatric Surgery – ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

University Medical Center New Orleans is expanding its Center for Weight Loss and Bariatric Surgery to meet the rising demand ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Time-restricted eating may improve blood glucose control and help reduce fat when coupled with standard nutritional ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

It is not a weight loss medication,” explains ... M.D., head of Medical Affairs at evidence-based weight care program Found, and practicing endocrinologist at an academic medical center in ...

Personalized weight loss programs in obese children are shown to reduce specific harmful lipids linked to heart disease and ...

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans ...